Vekov T[au] - Search Results

Year	Number of Results
2009	3
2011	2
2014	4
2015	2
2017	2
2018	3
2019	2
2020	4
2021	1
2022	1
2024	0

1

Encheva M, Djambazov S, Vekov T, Golicki D. Encheva M, et al. Among authors: vekov t. Eur J Health Econ. 2020 Nov;21(8):1169-1178. doi: 10.1007/s10198-020-01225-5. Epub 2020 Aug 19. Eur J Health Econ. 2020. PMID: 32813084

2

Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis.

Filipova E, Uzunova K, Kalinov K, Vekov T. Filipova E, et al. Among authors: vekov t. Diabetes Ther. 2017 Aug;8(4):705-726. doi: 10.1007/s13300-017-0273-4. Epub 2017 Jun 16. Diabetes Ther. 2017. PMID: 28623552 Free PMC article. Review.

3

Bosutinib: Valuable therapeutic option for the Bulgarian market.

Uzunova KH, Filipova EP, Vekov TY. Uzunova KH, et al. Among authors: vekov ty. J Cancer Res Ther. 2018 Jul-Sep;14(5):909-915. doi: 10.4103/jcrt.JCRT_604_16. J Cancer Res Ther. 2018. PMID: 30197324 Free article. Review.

4

Effects of pioglitazone therapy on blood parameters, weight and BMI: a meta-analysis.

Filipova E, Uzunova K, Kalinov K, Vekov T. Filipova E, et al. Among authors: vekov t. Diabetol Metab Syndr. 2017 Nov 14;9:90. doi: 10.1186/s13098-017-0290-5. eCollection 2017. Diabetol Metab Syndr. 2017. PMID: 29163673 Free PMC article. Review.

5

Combining angiotensin receptor blockers with chlorthalidone or hydrochlorothiazide - which is the better alternative? A meta-analysis.

Filipova E, Dineva S, Uzunova K, Pavlova V, Kalinov K, Vekov T. Filipova E, et al. Among authors: vekov t. Syst Rev. 2020 Aug 24;9(1):195. doi: 10.1186/s13643-020-01457-9. Syst Rev. 2020. PMID: 32838806 Free PMC article. Review.

6

Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2.

Uzunova K, Filipova E, Pavlova V, Vekov T. Uzunova K, et al. Among authors: vekov t. Biomed Pharmacother. 2020 Nov;131:110668. doi: 10.1016/j.biopha.2020.110668. Epub 2020 Aug 24. Biomed Pharmacother. 2020. PMID: 32861965 Free PMC article. Review.

7

Hydroxychloroquine (HCQ) Treatment for Hospitalized Patients with COVID- 19.

Tsanovska H, Simova I, Genov V, Kundurzhiev T, Krasnaliev J, Kornovski V, Dimitrov N, Vekov T. Tsanovska H, et al. Among authors: vekov t. Infect Disord Drug Targets. 2022;22(6):e030322201650. doi: 10.2174/1871526522666220303121209. Infect Disord Drug Targets. 2022. PMID: 35240966

8

Hydroxychloroquine for prophylaxis and treatment of COVID-19 in health-care workers.

Simova I, Vekov T, Krasnaliev J, Kornovski V, Bozhinov P. Simova I, et al. Among authors: vekov t. New Microbes New Infect. 2020 Nov;38:100813. doi: 10.1016/j.nmni.2020.100813. Epub 2020 Nov 12. New Microbes New Infect. 2020. PMID: 33204427 Free PMC article. No abstract available.

9

Comparative efficacy and safety of chlorthalidone and hydrochlorothiazide-meta-analysis.

Dineva S, Uzunova K, Pavlova V, Filipova E, Kalinov K, Vekov T. Dineva S, et al. Among authors: vekov t. J Hum Hypertens. 2019 Nov;33(11):766-774. doi: 10.1038/s41371-019-0255-2. Epub 2019 Oct 8. J Hum Hypertens. 2019. PMID: 31595024 Free PMC article.

10

Network meta-analysis of efficacy and safety of chlorthalidone and hydrochlorothiazide in hypertensive patients.

Dineva S, Uzunova K, Pavlova V, Filipova E, Kalinov K, Vekov T. Dineva S, et al. Among authors: vekov t. Blood Press Monit. 2021 Apr 1;26(2):160-168. doi: 10.1097/MBP.0000000000000486. Blood Press Monit. 2021. PMID: 32909966 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

24 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year